Skip to main contentSkip to footer
Farmer using cows to plough a field
Brighton & Sussex Medical School

Partners and collaborators

NIHR partners and collaborators

Meet our collaborating centres and partners.



The Centre for innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), based at the University of Addis Ababa in Ethiopia is a World Bank supported regional centre of excellence for education and research. CDT-Africa aims to improve equitable access to interventions (defined broadly to include medication, diagnostics and complex behavioural interventions) and bring about fair and sustainable development in Africa through high quality capacity development for drug discovery on a regional platform.  

more about CDT-Africa >

Prof Abebaw Fekadu, Centre Leader -


Mycetoma Research Centre

The Mycetoma Research Centre (MRC) is a global leader in Mycetoma management and research. The Centre was set up in 1991, at the University of Khartoum, and in 2015 was recognised as a WHO collaborating centre on Mycetoma. The main aim of the centre is to increase the quality of life for Mycetoma patients and generate evidence based developments in Mycetoma care.

The centre recognises the importance of taking a multidisciplinary approach to Mycetoma management, as holistic care includes medical, surgical and rehabilitative interventions. Community involvement is recognised as essential to improve care seeking behaviour and patient support, as most Mycetoma patients reside in resource poor and remote rural access. Research, innovation and the transfer of knowledge form the cornerstone of the MRC practice.

more about The Mycetoma Research Centre >

You can also download the MRC 2018 annual report.

Read The 2018 Mycetoma Research Centre report >


Dr Sahar M Bakhiet, Project Manager -
Prof Ahmed Hassan Fahal, Centre Leader - 

Armauer Hansen Research Institute 

The Armauer Hansen Research Institute (AHRI) is a leading African research institute, comprising well-equipped biomedical laboratories, experienced researchers and an extensive network of international and national partners.Through its research on important endemic diseases, AHRI is committed to building training capacity nationally and regionally. The Institute has a history of health research capacity building through support of postgraduate programmes at Ethiopian Universities, serving as a hub for skill and technology transfer into the country.The AHRI has a broad basic and translational infectious disease portfolio covering tuberculosis, leprosy, leishmaniasis, meningitis, malaria, HIV/STIs and sepsis. It works with universities, research institutions and health facilities across Ethiopia.

more about the Armauer Hansen Research Institute >

Rawleigh Howe